38 96
[34]
Rohrmann S, Linseisen J, Allen N, et al. Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2013;108:708–14.
[35]
Sawada N, Inoue M, Iwasaki M, et al. Alcohol and smoking and subsequent risk of prostate cancer in Japanese men: the Japan Public Health Center-based prospective study. Int J Cancer 2014;134:971–8.
[36]
Roberts WW, Platz EA, Walsh PC. Association of cigarette smoking with extraprostatic prostate cancer in young men. J Urol 2003; 169:512–6, discussion 516.
[37]
Pickles T, Liu M, Berthelet E, Kim-Sing C, Kwan W, Tyldesley S. The effect of smoking on outcome following external radiation for localized prostate cancer. J Urol 2004;171:1543–6.
[38]
Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Adamovich E. Effect of cigarette smoking on biochemical outcome after permanent prosatte brachytheraphy. Int J Radiat Oncol Biol Phys 2004;15:1056–62.[39]
Oefelein MG, Resnick MI. Association of tobacco use with hormone refractory disease and survival of patients with prostate cancer. J Urol 2004;71:2281–4.
[40]
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes Control 2008;19:25–31.
[41]
Kenfield SA, Stampfer MJ, Chan JM, Giovannucci E. Smoking and prostate cancer survival and recurrence. JAMA 2011;305:2548–55.
[42]
Joshu CE, Mondul AM, Meinhold CL, et al. Cigarette smoking and prostate cancer recurrence after prostatectomy. J Natl Cancer Inst 2011;18(103):835–8.
[43]
Dieperink KB, Hansen S, Wagner L, Johansen C, Andersen KK, Hansen O. Living alone, obesity and smoking: important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer. Acta Oncol 2012;51:722–9.
[44]
Oh JJ, Hong SK, Jeong CW, Byun SS, Lee SE. Significance of smoking status regarding outcomes after radical prostatectomy. Int Urol Nephrol 2012;44:119–24.
[45]
Ngo TC, Lee JJ, Brooks JD, Nolley R, Ferrari M, Presti Jr JC. Smoking and adverse outcomes at radical prostatectomy. Urol Oncol 2013;31: 749–54.[46]
Moreira DM, Aronson WJ, Terris MK, et al. Cigarette smoking is associated with an increased risk of biochemical disease recur- rence, metastasis, castration resistant prostate cancer and mortali- ty after radical prostatectomy: results from the SEARCH database. Cancer 2014;15(120):197–204.[47]
BurnsD, Lee L, Shen ZL,etal. Cigarettesmoking behaviorintheUnited
States.
In: Monograph
8:
changes
in
cigarette-related
disease
risks
and
their
implications
for
prevention
and
control.
Bethesda, MD:
National
Cancer
Institute;
2012.
p.
13–112.
http://cancercontrol. cancer.gov/Brp/tcrb/monographs/8/m8_2.pdf.
Updated
May
21,
2012.
[48]
Baliunas D, Patra J, Rehm J, Popova S, Kaiserman M, Taylor B. Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy. Chronic Dis Can 2007;27:154–62.
[49]
Ng M, Freeman MK, Fleming DT, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014; 311:183–92.
[50]
Nock NL, Tang D, Rundle A, et al. Associations between smok- ing, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race. Cancer Epidemiol Biomarkers Prev 2007;16: 1236–45.
[51]
Mao GE, Morris G, Lu QY, et al. Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 2004;28:368–74.[52]
Quin˜ones LA, Irarra´zabal CE, Rojas CR, et al. Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment inter- action study. Asian J Androl 2006;8:349–55.[53]
Birrane G, Li H, Yang S, Tachado SD, Seng S. Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: nuclear HO-1 promotes vascular endothelial growth factor secretion. Int J Oncol 2013;42:1919–28.
[54]
Miyake M, Fujimoto K, Anai S, et al. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder. Oncol Rep 2011;25:653–60.
[55]
Ye J, Wang S, Barger M, Castranova V, Shi X. Activation of androgen response element by cadmium: a potential mechanism for a carci- nogenic effect of cadmium in the prostate. J Environ Pathol Toxicol Oncol 2000;19:275–80.
[56]
Plaskon LA, Penson DF, Vaughan TL, Stanford JL. Cigarette smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol Biomarkers Prev 2003;12:604–9.[57]
Shiels MS, Rohrmann S, Menke A, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex ste- roid hormone levels in US men. Cancer Causes Control 2009;20: 877–86.
[58]
De Nunzio C, Kramer G, Marberger M, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol 2011;60:106–17.
[59]
Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immu- nity, inflammation and autoimmunity. J Autoimmun 2010;34: J258–65.
[60]
Moreira D, Nickel JC, Gerber L, et al. Smoking is associated with acute prostatic inflammation in men with a negative prostate biopsy: results from the REDUCE study. J Urol 2013;189:e480.[61]
Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health 2010;100:693–701.
[62]
Ho
TS,
Howard
LE,
Vidal
AC,
et
al.
Smoking
and
risk
of
low-
and
high-grade
prostate
cancer:
results
from
the
REDUCE
study.
Clin
Cancer
Res.
In
press.
[63]
Muller RL, Moreira DM. Smoking and prostate cancer survival and recurrence. Asian J Androl 2011;13:787–8.
[64]
Weaver KE, Danhauer SC, Tooze JA, et al. Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. Oncologist 2012;17:455–62.
[65]
Fiore MC, Jaen CR, Baker TB, et al. Treating tobacco use and dependence: 2008 update US Public Health Service Clinical Practice Guideline executive summary. Respir Care 2008;53:1217–22.
[66]
Pentz RD, Berg CJ. Smoking and ethics: what are the duties of oncologists? Oncologist 2010;15:987–93.
[67]
Rolison JJ, Hanoch Y, Miron-Shatz T. Smokers: at risk for prostate cancer but unlikely to screen. Addict Behav 2012;37:736–8.[68]
Li J, Thompson T, Joseph DA, Master VA. Association between smoking status, and free, total and percent free prostate specific antigen. J Urol 2012;187:1228–33.
E U R O P E A N
U R O L O G Y
F O C U S
1
( 2 0 1 5
)
2 8 – 3 8
38